Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
FI972430A7 - Monoclonal antibody fragments with immunosuppressive activity - Google Patents
[go: Go Back, main page]

FI972430A7 - Monoclonal antibody fragments with immunosuppressive activity - Google Patents

Monoclonal antibody fragments with immunosuppressive activity Download PDF

Info

Publication number
FI972430A7
FI972430A7 FI972430A FI972430A FI972430A7 FI 972430 A7 FI972430 A7 FI 972430A7 FI 972430 A FI972430 A FI 972430A FI 972430 A FI972430 A FI 972430A FI 972430 A7 FI972430 A7 FI 972430A7
Authority
FI
Finland
Prior art keywords
monoclonal antibody
antibody fragments
immunosuppressive activity
immunosuppressive
activity
Prior art date
Application number
FI972430A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972430A0 (en
FI972430L (en
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI972430A7 publication Critical patent/FI972430A7/en
Publication of FI972430A0 publication Critical patent/FI972430A0/en
Publication of FI972430L publication Critical patent/FI972430L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI972430A 1994-12-07 1995-11-25 Monoclonal antibody fragments with immunosuppressive activity FI972430L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (3)

Publication Number Publication Date
FI972430A7 true FI972430A7 (en) 1997-06-06
FI972430A0 FI972430A0 (en) 1997-06-06
FI972430L FI972430L (en) 1997-06-06

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972430A FI972430L (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments with immunosuppressive activity

Country Status (19)

Country Link
EP (1) EP0787151A1 (en)
JP (1) JP2001506122A (en)
CN (1) CN1168679A (en)
AR (1) AR002005A1 (en)
AU (1) AU4256096A (en)
BR (1) BR9509902A (en)
CA (1) CA2206471A1 (en)
CO (1) CO4480041A1 (en)
CZ (1) CZ172497A3 (en)
FI (1) FI972430L (en)
HU (1) HUT77342A (en)
IL (1) IL116228A0 (en)
MA (1) MA23739A1 (en)
NO (1) NO972522L (en)
PE (1) PE52996A1 (en)
PL (1) PL320610A1 (en)
TR (1) TR199501542A2 (en)
WO (1) WO1996017874A1 (en)
ZA (1) ZA9510195B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) * 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156060B1 (en) * 2000-05-12 2007-06-27 GPC Biotech AG Human peptides/proteins causing or leading to the killing of cells including lymphoid tumor cells
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US6894149B2 (en) 2001-10-11 2005-05-17 Protein Design Labs, Inc. Anti-HLA-DA antibodies and the methods of using thereof
US7262278B2 (en) 2001-10-15 2007-08-28 Kirin Beer Kabushiki Kaisha Anti-HLA-DR antibody
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2794499A1 (en) * 2010-04-01 2011-10-06 Immumomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (en) * 2021-07-22 2024-03-14 서울대학교산학협력단 Anti-HLA-DP monoclonal antibody and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
DE69028713T3 (en) * 1989-12-27 2004-05-13 Centocor, Inc. CHIMERAL IMMUNOGLOBULINE FOR CD4 RECEPTORS
ES2196002T3 (en) * 1991-07-25 2003-12-16 Idec Pharma Corp RECOMBINANT ANTIBODIES FOR HUMAN THERAPY.

Also Published As

Publication number Publication date
BR9509902A (en) 1997-10-21
AR002005A1 (en) 1998-01-07
AU4256096A (en) 1996-06-26
JP2001506122A (en) 2001-05-15
CA2206471A1 (en) 1996-06-13
TR199501542A2 (en) 1996-07-21
PL320610A1 (en) 1997-10-13
EP0787151A1 (en) 1997-08-06
CN1168679A (en) 1997-12-24
NO972522L (en) 1997-08-06
IL116228A0 (en) 1996-03-31
FI972430A0 (en) 1997-06-06
NO972522D0 (en) 1997-06-03
ZA9510195B (en) 1996-06-07
WO1996017874A1 (en) 1996-06-13
CZ172497A3 (en) 1997-10-15
MX9704225A (en) 1997-09-30
HUT77342A (en) 1998-03-30
FI972430L (en) 1997-06-06
PE52996A1 (en) 1996-12-12
MA23739A1 (en) 1996-07-01
CO4480041A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
NO955167D0 (en) Monoclonal anti-
DK1516629T3 (en) Humanized anti-CD-11a antibodies
DK145493D0 (en) ANTIBODY
DE69920897D1 (en) MONOCLONAL ANTIBODIES WITH REDUCED IMMUNIZABILITY
IL128406A0 (en) Monoclonal antibodies
DE69617896D1 (en) Human monoclonal antibody against VEGF
FI965032L (en) Interleukin-5-specific recombinant antibodies
DK666389D0 (en) MONOCLONAL ANTIBODY
FI964845A7 (en) Anti-CD44v6 monoclonal antibodies
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
FI945865A7 (en) Monoclonal antibodies directed against glycoprofen P
DE69738312D1 (en) HEPATITIS B MONOCLONAL ANTIBODIES
FI972430A7 (en) Monoclonal antibody fragments with immunosuppressive activity
FI895287A7 (en) Anti-fucosylceramide monoclonal antibody
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
DE69023717D1 (en) Monoclonal antibody.
EP0640621A3 (en) Monoclonal anti-thrombin antibody.
DE69427850D1 (en) MONOCLONAL ANTIBODY AGAINST MUCOGLYCOPROTEIN
BR9709080A (en) Human anti-MP52 monoclonal antibody
DE69324928D1 (en) MONOCLONAL ANTIBODY
GB9615027D0 (en) Monoclonal antibodies
KR970030549U (en) Fuel chiller
KR960033941U (en) Flywheel buffer
DK220688D0 (en) MONOCLONAL ANTIBODY